A New Prognostic Scoring System for Spontaneous Ruptured Hepatocellular
NCT ID: NCT03504358
Last Updated: 2018-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
129 participants
OBSERVATIONAL
2005-01-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Spontaneous Ruptured Hepatocellular Carcinoma
NCT03516890
A Comparison Between Child-Pugh and Albumin-Bilirubin Scores
NCT03534843
Long-term Management of Patients With Ruptured HCC
NCT06505291
A Novel MSE Score to Predict rHCC Patients
NCT05450874
Predictors and Outcome of Rupture HCC in AU Hospitals
NCT07291674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Analysis before liver resection
Multivariate analysis of predictive factors associated with survival
Liver resection
Partial hepatectomy comprised single or multiple hepatic resections aiming at excising all visible malignant tissue.
Different risk group
Low-risk group, moderate-risk group, high-risk group
Liver resection
Partial hepatectomy comprised single or multiple hepatic resections aiming at excising all visible malignant tissue.
Model comparison
Comparison of models in predicting survival
Liver resection
Partial hepatectomy comprised single or multiple hepatic resections aiming at excising all visible malignant tissue.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liver resection
Partial hepatectomy comprised single or multiple hepatic resections aiming at excising all visible malignant tissue.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huazhong University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaoping Chen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bi-xiang Zhang, Prof, PHD
Role: STUDY_CHAIR
Huazhong University of Science and Technology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zhupeng002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.